Tepotinib, sold under the brand name Tepmetko, is an anti-cancer medication used for the treatment of adults with non-small cell lung cancer (NSCLC).
{{Infobox drug | image = Tepotinib.svg | image_class = skin-invert-image | width = | alt = | caption = | image2 = Tepotinib ball-and-stick 4R1V.png | image_class2 = bg-transparent | alt2 =
| pronounce = | tradename = Tepmetko | Drugs.com = | MedlinePlus = a621012 | DailyMedID = Tepotinib | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category= Not recommended | routes_of_administration = By mouth | class = | ATC_prefix = L01 | ATC_suffix = EP02 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).